Sklenovska N, Van Ranst M. Emergence of Monkeypox as the most important orthopoxvirus infection in humans. Front Public Health. 2018;6:241.

Article  PubMed  PubMed Central  Google Scholar 

Hutson CL, Nakazawa YJ, Self J, et al. Laboratory investigations of african pouched rats (Cricetomys gambianus) as a potential reservoir host species for monkeypox virus. Plos Neglect Trop D. 2015;9(10): e0004013.

Article  Google Scholar 

Falendysz EA, Lopera JG, Doty JB, et al. Characterization of monkeypox virus infection in African rope squirrels (Funisciurus sp.). Plos Neglect Trop D. 2017;11(8): e0005809.

Article  Google Scholar 

Arita I, Henderson DA. Smallpox and monkeypox in non-human primates. B World Health Organ. 1968;39(2):277–83.

CAS  Google Scholar 

Vaughan A, Aarons E, Astbury J, et al. Human-to-human transmission of monkeypox virus, United Kingdom, October 2018. Emerg Infect Dis. 2020;26(4):782–5.

Article  PubMed Central  CAS  Google Scholar 

Hutson CL, Carroll DS, Gallardo-Romero N, et al. Monkeypox disease transmission in an experimental setting: prairie dog animal model. PLoS ONE. 2011;6(12): e28295.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Jezek Z, Grab B, Szczeniowski MV, Paluku KM, Mutombo M. Human monkeypox: secondary attack rates. Bull World Health Organ. 1988;66(4):465–70.

PubMed  PubMed Central  CAS  Google Scholar 

2022 monkeypox outbreak global map. U.S. Department of health & human services; 2022. https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html. Accessed Aug 18, 2022.

World health organization. Monkeypox outbreak 2022. The WHO. https://www.who.int/emergencies/situations/monkeypox-oubreak-2022. Published 2022. Accessed Aug 18, 2022.

Americo JL, Earl PL, Moss B. Virulence differences of mpox (monkeypox) virus clades I, IIa, and IIb.1 in a small animal model. Proc Natl Acad Sci U S A. 2023;120(8): e2220415120.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Thornhill JP, Barkati S, Walmsley S, et al. Monkeypox virus infection in humans across 16 countries - April-June 2022. N Engl J Med. 2022;387(25): e69.

Article  PubMed  Google Scholar 

World health organization. Monkeypox: key facts. The WHO. https://www.who.int/news-room/fact-sheets/detail/monkeypox. Published 2022. Accessed Aiugust 18, 2022.

European medicines agency. Tecovirimat SIGA. The European medicines agency. https://www.ema.europa.eu/en/medicines/human/EPAR/tecovirimat-siga. Published 2022. Accessed Aug 18, 2022.

Siegrist EA, Sassine J. Antivirals with activity against Mpox: a clinically oriented review. Clin Infect Dis. 2023;76(1):155–64.

Article  PubMed  CAS  Google Scholar 

Centers for disease control and prevention. Treatment information for healthcare professionals. U.S. Department of health & human services. https://www.cdc.gov/poxvirus/mpox/clinicians/treatment.html#:~:text=The%20medical%20countermeasures%20currently%20available,Cidofovir%20is%20also%20available%20commercially. Published 2023. Accessed April 12, 2023.

World Health Organization. WHO handbook for guideline development. In: Vol 11. 2nd ed. Geneva, Switzerland: World health organization; 2014: https://apps.who.int/iris/handle/10665/145714 Accessed Nov 10, 2022.

Okoli GN, Van Caeseele P, Askin N, Abou-Setta AM. Comparative evaluation of the clinical presentation and epidemiology of the 2022 and previous Mpox outbreaks: a rapid review and meta-analysis. Infect Dis (Lond). 2023;55(7):490–508.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.

Article  PubMed  PubMed Central  Google Scholar 

McGowan J, Sampson M, Salzwedel DM, Cogo E, Foerster V, Lefebvre C. PRESS peer review of electronic search strategies: 2015 guideline statement. J Clin Epidemiol. 2016;75:40–6.

Article  PubMed  Google Scholar 

EndNote [computer program]. Version EndNote X9. Philadelphia, PA: Clarivate; 2013.

Shaw FE, Kohl KS, Lee LM, Thacker SB. Introduction: Supplements. Morb Mortal Wkly Rep. 2011;60(04):2–6.

Google Scholar 

Sterne JAC, Savovic J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. Bmj-Brit Med J. 2019;366: l4898.

Article  Google Scholar 

Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analysis. Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Published 2011. Accessed Feb 9, 2023.

Abesig J, Chen Y, Wang H, Sompo FM, Wu IXY. Prevalence of viral hepatitis B in Ghana between 2015 and 2019: a systematic review and meta-analysis. PLoS ONE. 2020;15(6): e0234348.

Article  PubMed  PubMed Central  CAS  Google Scholar 

DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–88.

Article  PubMed  CAS  Google Scholar 

Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.

Article  PubMed  Google Scholar 

Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.

Article  PubMed  PubMed Central  Google Scholar 

Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857–72.

Article  PubMed  CAS  Google Scholar 

Lin LF, Xu C. Arcsine-based transformations for meta-analysis of proportions: pros, cons, and alternatives. Health Sci Rep-Us. 2020;3(3): e178.

Article  Google Scholar 

Doi SA, Xu C. The Freeman-Tukey double arcsine transformation for the meta-analysis of proportions: recent criticisms were seriously misleading. J Evid-Based Med. 2021;14(4):259–61.

Article  PubMed  Google Scholar 

Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.

Article  PubMed  Google Scholar 

Alpalhao M, Sousa D, Frade JV, et al. Human immunodeficiency virus infection may be a contributing factor to monkeypox infection: analysis of a 42-case series. J Am Acad Dermatol. 2023;88(3):720–2.

Article  PubMed  Google Scholar 

Angelo KM, Smith T, Camprubi-Ferrer D, et al. Epidemiological and clinical characteristics of patients with monkeypox in the geosentinel network: a cross-sectional study. Lancet Infect Dis. 2023;23(2):196–206.

Article  PubMed  CAS  Google Scholar 

Antoine M, Rubenstein E, Lascoux-Combe C, et al. Clinical description of sixty-six cases of monkeypox virus (MKPV) Infection among men who have sex with men (MSM) in an HIV/PrEP French clinic. Jaids-J Acq Imm Def. 2023;92(3):E11–4.

Google Scholar 

Aromolo IF, Maronese CA, Avallone G, et al. Clinical spectrum of human monkeypox: an Italian single-centre case series. J Eur Acad Dermatol Venereol. 2023;37(3):e368–71.

Article  PubMed  Google Scholar 

Assiri AM, Al-Tawfiq JA, Jokhdar HA, et al. Clinical features and outcome of human Mpox (Monkeypox) in Saudi Arabia: an observational study of travel-related cases. J Infect Public Health. 2023;16(3):341–5.

Article  PubMed  PubMed Central  Google Scholar 

Berens-Riha N, De Block T, Rutgers J, et al. Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022. Euro Surveill. 2022;27(48):2200894.

Article  PubMed  PubMed Central  Google Scholar 

Bertin C, Beaumont AL, Merlant M, et al. Erythematous maculopapular rash in monkeypox virus infection: a retrospective case series of 30 patients. J Eur Acad Dermatol Venereol. 2023;37(5):e638–41.

Article  PubMed  Google Scholar 

Betancort-Plata C, Lopez-Delgado L, Jaen-Sanchez N, et al. Monkeypox and HIV in the canary islands: a different pattern in a mobile population. Trop Med Infect Dis. 2022;7(10):318.

Article  PubMed  PubMed Central  Google Scholar 

Caria J, Pinto R, Leal E, et al. Clinical and epidemiological features of hospitalized and ambulatory patients with human monkeypox infection: a retrospective observational study in Portugal. Infect Dis Rep. 2022;14(6):810–23.

Article  PubMed  PubMed Central  Google Scholar 

Cassir N, Cardona F, Tissot-Dupont H, et al. Observational cohort study of evolving epidemiologic, clinical, and virologic features of monkeypox in Southern France. Emerg Infect Dis. 2022;28(12):2409–15.

Article  PubMed  PubMed Central  Google Scholar 

Catala A, Clavo-Escribano P, Riera-Monroig J, et al. Monkeypox outbreak in Spain: clinical and epidemiological findings in a prospective cross-sectional study of 185 cases. Br J Dermatol. 2022;187(5):765–72.

Article  PubMed  Google Scholar 

Cobos A, Valerio M, Palomo M, et al. Demographic, clinical and microbiological characteristics of the first 30 human monkeypox confirmed cases attended in a tertiary hospital in Madrid (Spain), during the May-June 2022 international outbreak. Rev Esp Quimioter. 2023;36(2):194–200.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Desai AN, Thompson GR 3rd, Neumeister SM, Arutyunova AM, Trigg K, Cohen SH. Compassionate use of tecovirimat for the treatment of monkeypox infection. JAMA. 2022;328(13):1348–50.

Article  PubMed  PubMed Central  CAS  Google Scholar 

Fink DL, Callaby H, Luintel A, et al. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study. Lancet Infect Dis. 2023;23(5):589–97.

Article  PubMed